TW200630092A - Inhibitors of c-fms kinase - Google Patents
Inhibitors of c-fms kinaseInfo
- Publication number
- TW200630092A TW200630092A TW094136915A TW94136915A TW200630092A TW 200630092 A TW200630092 A TW 200630092A TW 094136915 A TW094136915 A TW 094136915A TW 94136915 A TW94136915 A TW 94136915A TW 200630092 A TW200630092 A TW 200630092A
- Authority
- TW
- Taiwan
- Prior art keywords
- cancer
- diseases
- treating
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/70—Nitro radicals
- C07D307/71—Nitro radicals attached in position 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62121104P | 2004-10-22 | 2004-10-22 | |
US67017205P | 2005-04-11 | 2005-04-11 | |
US11/254,276 US7662837B2 (en) | 2004-10-22 | 2005-10-20 | Inhibitors of c-fms kinase |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200630092A true TW200630092A (en) | 2006-09-01 |
TWI377942B TWI377942B (en) | 2012-12-01 |
Family
ID=40433511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094136915A TWI377942B (en) | 2004-10-22 | 2005-10-21 | Inhibitors of c-fms kinase |
Country Status (10)
Country | Link |
---|---|
US (1) | US7662837B2 (zh) |
AR (1) | AR051599A1 (zh) |
EC (1) | ECSP077409A (zh) |
IL (1) | IL182735A (zh) |
MY (1) | MY145668A (zh) |
NZ (1) | NZ555289A (zh) |
PE (1) | PE20060724A1 (zh) |
SV (1) | SV2006002669A (zh) |
TW (1) | TWI377942B (zh) |
UY (1) | UY29178A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7645755B2 (en) * | 2004-10-22 | 2010-01-12 | Janssen Pharmaceutical N.V. | Inhibitors of c-fms kinase |
US20060281788A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor |
JP5331681B2 (ja) * | 2006-04-20 | 2013-10-30 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | c−fmsキナーゼの阻害剤 |
WO2007124316A1 (en) * | 2006-04-20 | 2007-11-01 | Janssen Pharmaceutica N.V. | Heterocyclic compounds as inhibitors of c-fms kinase |
MX2008013532A (es) * | 2006-04-20 | 2009-01-15 | Janssen Pharmaceutica Nv | Inhibidores de c-fms cinasa. |
US8697716B2 (en) | 2006-04-20 | 2014-04-15 | Janssen Pharmaceutica Nv | Method of inhibiting C-KIT kinase |
JO3240B1 (ar) * | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
EP2882757B1 (en) | 2012-08-07 | 2016-10-05 | Janssen Pharmaceutica, N.V. | Process for the preparation of heterocyclic ester derivatives |
JOP20180012A1 (ar) | 2012-08-07 | 2019-01-30 | Janssen Pharmaceutica Nv | عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190541A (en) * | 1990-10-17 | 1993-03-02 | Boston Scientific Corporation | Surgical instrument and method |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
US5702390A (en) * | 1996-03-12 | 1997-12-30 | Ethicon Endo-Surgery, Inc. | Bioplar cutting and coagulation instrument |
UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
US6100254A (en) * | 1997-10-10 | 2000-08-08 | Board Of Regents, The University Of Texas System | Inhibitors of protein tyrosine kinases |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
DK1140938T3 (da) * | 1999-01-11 | 2003-12-22 | Univ Princeton | Højaffinitetsinhibitorer for målvalidering og anvendelser heraf |
PL215901B1 (pl) * | 1999-04-15 | 2014-02-28 | Bristol Myers Squibb Co | Cykliczny inhibitor bialkowych kinaz tyrozynowych, jego zastosowanie oraz kompozycja farmaceutyczna zawierajaca taki zwiazek |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US6346625B1 (en) * | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
EP1242385B1 (en) | 1999-12-28 | 2009-11-25 | Pharmacopeia, Inc. | Cytokine, especially tnf-alpha, inhibitors |
US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
US6692491B1 (en) * | 2000-03-24 | 2004-02-17 | Scimed Life Systems, Inc. | Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures |
US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6613809B2 (en) * | 2001-11-28 | 2003-09-02 | The Regents Of The University Of California | Metal-doped organic gels and method thereof |
TW200500362A (en) * | 2003-04-09 | 2005-01-01 | Japan Tobacco Inc | 5-membered heteroaromatic ring compound and pharmaceutical use thereof |
MXPA05011503A (es) * | 2003-04-25 | 2006-05-31 | Johnson & Johnson | Inhibidores de la c-fms cinasa. |
US7645755B2 (en) * | 2004-10-22 | 2010-01-12 | Janssen Pharmaceutical N.V. | Inhibitors of c-fms kinase |
-
2005
- 2005-10-20 NZ NZ555289A patent/NZ555289A/en not_active IP Right Cessation
- 2005-10-20 US US11/254,276 patent/US7662837B2/en not_active Expired - Fee Related
- 2005-10-21 TW TW094136915A patent/TWI377942B/zh not_active IP Right Cessation
- 2005-10-21 MY MYPI20054962A patent/MY145668A/en unknown
- 2005-10-21 PE PE2005001242A patent/PE20060724A1/es active IP Right Grant
- 2005-10-24 AR ARP050104445A patent/AR051599A1/es not_active Application Discontinuation
- 2005-10-24 UY UY29178A patent/UY29178A1/es not_active Application Discontinuation
-
2006
- 2006-08-24 SV SV2006002669A patent/SV2006002669A/es unknown
-
2007
- 2007-04-20 EC EC2007007409A patent/ECSP077409A/es unknown
- 2007-04-22 IL IL182735A patent/IL182735A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MY145668A (en) | 2012-03-15 |
AR051599A1 (es) | 2007-01-24 |
ECSP077409A (es) | 2007-05-30 |
US7662837B2 (en) | 2010-02-16 |
IL182735A0 (en) | 2007-09-20 |
IL182735A (en) | 2013-10-31 |
US20060148812A1 (en) | 2006-07-06 |
TWI377942B (en) | 2012-12-01 |
PE20060724A1 (es) | 2006-09-01 |
NZ555289A (en) | 2010-10-29 |
SV2006002669A (es) | 2009-10-15 |
UY29178A1 (es) | 2006-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA88648C2 (en) | Inhibitors of c-fms kinase | |
UA93085C2 (en) | Inhibitors of c-fms kinase | |
PT2021335E (pt) | Compostos heterocíclicos como inibidores de c-fms quinase | |
JO3240B1 (ar) | c-fms مثبطات كيناز | |
ATE437864T1 (de) | Aromatische amide als hemmer der c-fms-kinase | |
MY145668A (en) | Inhibitors of c-fms kinase | |
EA201400575A1 (ru) | Способы получения ингибиторов jak киназ и родственных промежуточных соединений | |
GEP201706639B (en) | Heterocyclic compounds and uses thereof | |
IL283184B2 (en) | Crystal polymorph of (7s,13r)-11-fluoro-7,13-dimethyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10] benzoxatriazacyclotridecin–4(5h)–one for the treatment of cancer | |
RS20050810A (en) | 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension | |
NZ600631A (en) | Heteroaryl compounds and uses thereof | |
UA94622C2 (en) | Kinase innhibitor | |
IN2014DN06567A (zh) | ||
MY157368A (en) | Pyrrolo pyrimidines as agents for the inhibition of cystein proteases | |
NZ594383A (en) | Aminopyrimidines useful as kinase inhibitors | |
TW200519096A (en) | Quinazoline analogs as receptor tyrosine kinase inhibitors | |
MY143516A (en) | Kinase inhibitors | |
EP3102571B1 (en) | Substituted pyrimidines useful as egfr-t790m kinase inhibitors | |
TW200602348A (en) | Thieno[3, 2-b]pyridine-6-carbonitriles as protein kinase inhibitors | |
MX2009011059A (es) | Aminopirimidinas utiles como inhibidores de cinasas. | |
UA98928C2 (ru) | 1,4-дигидропиридинконденсированные гетероциклы, способ их получения, применения и композиция, которая содержит их | |
EA030937B1 (ru) | Соединения 1,3,4-тиадиазола и их применение в лечении рака | |
MX2011012631A (es) | Inhibidores de actividad de cinasa tipo pirimidina. | |
UA90659C2 (ru) | Аналоги хиназолина как ингибиторы рецепторных тирозинкиназ | |
TW200720225A (en) | New one-step synthesis of useful disubstituted amines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |